Clinical Trials on BRAF in Finland
Total 1 results
-
Fore BiotherapeuticsRecruitingCancer Harboring BRAF AlterationsUnited States, Germany, Spain, United Kingdom, France, Korea, Republic of, Italy, Sweden, Canada
Sponsors and Collaborators
- Stanford's Innovative Medicines Accelerator
- Ondine Biomedical Inc.
- AVAX Technologies
- National Institute of Drug Abuse
- Spokane Regional Health District
- Prostate Cure Foundation
- Rotem Petranker
- Azumio Inc.
- Robert Pendleton
- Montera Health Texas LLC
- Genesis Foundation
- Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
- Health Factors Inc
- Manresana de Micobacteriologia, SL
- Michael Scharl
- University Mental Health Research Institute, Athens, Greece
- Daqiao Community Health Service Center of Yangpu District
- National Institute of Diabetes and Endocrinology, Egypt
- Ancon Technologies Ltd
- Julie Lefevere
- View Full List
Medical Conditions
- Tumor, Benign
- Germinal Center B-cell Type (GCB)
- To Analyze the Frequency of Posttraumatic Stress Disorder in Cases With Awareness and Possible Awareness
- Spondylitis Secondary to Inflammatory Bowel Disease
- Acute Myocardial Infraction or Chest Pain
- Periprosthetic Fracture of the Upper or Lower Limb
- Severe Haemophilia A
- Associated Conditions
- Five-year Survival Rate
- Intramural Haematoma of Thoracic Aorta
- Benign Lymphoproliferative Disorder
- Maxillary Deficiency
- Disorder of Nipple
- Lack of Drug Action
- Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
- Attention Deficit Hyperactivity Disorder Symptoms
- Focal Cortical Dysplasia
- Heart Failure With Reduced Ejection Fraction (HFrEF)
- FIGO Stage III Primary Peritoneal Cancer
- Stimulant Use (Diagnosis)
- View Full List
Drug Interventions
- Colchicine group (experimental arm)
- Nab-paclitaxel
- PD-0332991
- Zydena (Udenafil) 100mg + Donepezil 5mg or 10mg
- Bevacizumab
- Uprifosbuvir
- Ciclesonide
- Single dose of vepdegestrant as tablet formulation (Treatment A)
- JNJ 10229570-AAA 3.6% cream
- GM-CSF
- Formulation N3
- Glycopyrrolate
- G-CSF
- Administration of etoricoxib
- DKN-01
- Megestrol Acetate 160 MG
- Human menopausal gonadotropin
- Mild sedation and analgesia
- Treament C
- Golcadomide
- View Full List
CROs by country
- Contract Research Organizations in Canada
- Contract Research Organizations in Denmark
- Contract Research Organizations in France
- Contract Research Organizations in Gabon
- Contract Research Organizations in Ireland
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Morocco
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Poland
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Uganda
- Contract Research Organizations in Zimbabwe
- CRO list by country